Top

Published in:

Open Access 01-04-2011

Cardiovascular Applications of Hyperpolarized MRI

Author: Damian J. Tyler

Published in: Current Cardiovascular Imaging Reports | Issue 2/2011

Abstract

Many applications of MRI are limited by an inherently low sensitivity. Previous attempts to overcome this insensitivity have focused on the use of MRI systems with stronger magnetic fields. However, the gains that can be achieved in this way are relatively small and increasing the magnetic field invariably leads to greater technical challenges. More recently, the development of a range of techniques, which can be gathered under the umbrella term of “hyperpolarization,” has offered potential solutions to the low sensitivity. Hyperpolarization techniques have been demonstrated to temporarily increase the signal available in an MRI experiment by as much as 100,000-fold. This article outlines the main hyperpolarization techniques that have been proposed and explains how they can increase MRI signals. With particular emphasis on the emerging technique of dynamic nuclear polarization, the existing preclinical cardiovascular applications are reviewed and the potential for clinical translation is discussed.

Mansson, S., E. Johansson, P. Magnusson, et al., 13C imaging-a new diagnostic platform. Eur Radiol, 2006. 16(1): p. 57–67.PubMedCrossRef

Bhattacharya, P., B.D. Ross and R. Bunger, Cardiovascular applications of hyperpolarized contrast media and metabolic tracers. Exp Biol Med (Maywood), 2009. 234(12): p. 1395–416.CrossRef

Comment, A., B. van den Brandt, K. Uffmann, et al., Design and performance of a DNP prepolarizer coupled to a rodent MRI scanner. Concepts in Magnetic Resonance Part B-Magnetic Resonance Engineering, 2007. 31B(4): p. 255–269.CrossRef

Fain, S.B., F.R. Korosec, J.H. Holmes, et al., Functional lung imaging using hyperpolarized gas MRI. J Magn Reson Imaging, 2007. 25(5): p. 910–23.PubMedCrossRef

Viale, A., F. Reineri, D. Santelia, et al., Hyperpolarized agents for advanced MRI investigations. Q J Nucl Med Mol Imaging, 2009. 53(6): p. 604–17.PubMed

Ardenkjaer-Larsen, J.H., B. Fridlund, A. Gram, et al., Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR. Proc Natl Acad Sci U S A, 2003. 100(18): p. 10158–63.PubMedCrossRef

Day, S.E., M.I. Kettunen, F.A. Gallagher, et al., Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy. Nat Med, 2007. 13(11): p. 1382–7.PubMedCrossRef

Golman, K., R.I. Zandt, M. Lerche, et al., Metabolic imaging by hyperpolarized 13C magnetic resonance imaging for in vivo tumor diagnosis. Cancer Res, 2006. 66(22): p. 10855–60.PubMedCrossRef

•• Golman, K., J.S. Petersson, P. Magnusson, et al., Cardiac metabolism measured noninvasively by hyperpolarized 13C MRI. Magn Reson Med, 2008. 59(5): p. 1005–13. This article demonstrates the potential for hyperpolarized MRI to image the regional distribution of different metabolic products in normal and post-ischemic hearts. PubMedCrossRef

10.

• Merritt, M.E., C. Harrison, C. Storey, et al., Hyperpolarized 13C allows a direct measure of flux through a single enzyme-catalyzed step by NMR. Proc Natl Acad Sci U S A, 2007. 104(50): p. 19773–7. This article demonstrates the utility of hyperpolarized pyruvate in the perfused heart and shows that altered PDH flux can be assessed with high temporal resolution. PubMedCrossRef

11.

•• Schroeder, M.A., L.E. Cochlin, L.C. Heather, et al., In vivo assessment of pyruvate dehydrogenase flux in the heart using hyperpolarized carbon-13 magnetic resonance. Proc Natl Acad Sci U S A, 2008. 105(33): p. 12051–6. This is the first manuscript to use hyperpolarized pyruvate to assess the in vivo rat heart and to demonstrate the alterations to in vivo PDH flux caused by overnight fasting and type 1 diabetes. PubMedCrossRef

12.

• Golman, K. and J.S. Petersson, Metabolic imaging and other applications of hyperpolarized 13C1. Acad Radiol, 2006. 13(8): p. 932–42. This is an excellent review of the preliminary work exploring the potential applications of hyperpolarized MRI. PubMedCrossRef

13.

Ross, B.D., P. Bhattacharya, S. Wagner, et al., Hyperpolarized MR imaging: neurologic applications of hyperpolarized metabolism. AJNR Am J Neuroradiol, 2010. 31(1): p. 24–33.PubMedCrossRef

14.

Golman, K., J.H. Ardenkjaer-Larsen, J.S. Petersson, et al., Molecular imaging with endogenous substances. Proc Natl Acad Sci U S A, 2003. 100(18): p. 10435–9.PubMedCrossRef

15.

Golman, K., O. Axelsson, H. Johannesson, et al., Parahydrogen-induced polarization in imaging: subsecond (13)C angiography. Magn Reson Med, 2001. 46(1): p. 1–5.PubMedCrossRef

16.

Svensson, J., S. Mansson, E. Johansson, et al., Hyperpolarized 13C MR angiography using trueFISP. Magn Reson Med, 2003. 50(2): p. 256–62.PubMedCrossRef

17.

Olsson, L.E., C.M. Chai, O. Axelsson, et al., MR coronary angiography in pigs with intraarterial injections of a hyperpolarized 13C substance. Magn Reson Med, 2006. 55(4): p. 731–7.PubMedCrossRef

18.

Ishii, M., K. Emami, S. Kadlecek, et al., Hyperpolarized 13C MRI of the pulmonary vasculature and parenchyma. Magn Reson Med, 2007. 57(3): p. 459–63.PubMedCrossRef

19.

Schwitter, J., Myocardial perfusion imaging by cardiac magnetic resonance. J Nucl Cardiol, 2006. 13(6): p. 841–54.PubMedCrossRef

20.

Johansson, E., L.E. Olsson, S. Mansson, et al., Perfusion assessment with bolus differentiation: a technique applicable to hyperpolarized tracers. Magn Reson Med, 2004. 52(5): p. 1043–51.PubMedCrossRef

21.

Johansson, E., S. Mansson, R. Wirestam, et al., Cerebral perfusion assessment by bolus tracking using hyperpolarized 13C. Magn Reson Med, 2004. 51(3): p. 464–72.PubMedCrossRef

22.

Magnusson, P., E. Johansson, S. Mansson, et al., Passive catheter tracking during interventional MRI using hyperpolarized 13C. Magn Reson Med, 2007. 57(6): p. 1140–7.PubMedCrossRef

23.

Horowitz, J.D. and J.A. Kennedy, Time to address the cardiac metabolic “triple whammy” ischemic heart failure in diabetic patients. J Am Coll Cardiol, 2006. 48(11): p. 2232–4.PubMedCrossRef

24.

Neubauer, S., The failing heart—an engine out of fuel. N Engl J Med, 2007. 356(11): p. 1140–51.PubMedCrossRef

25.

Stanley, W.C., F.A. Recchia and G.D. Lopaschuk, Myocardial substrate metabolism in the normal and failing heart. Physiol Rev, 2005. 85(3): p. 1093–129.PubMedCrossRef

26.

Bailey, I.A., D.G. Gadian, P.M. Matthews, et al., Studies of metabolism in the isolated, perfused rat heart using 13C NMR. FEBS Lett, 1981. 123(2): p. 315–8.PubMedCrossRef

27.

Lloyd, S., C. Brocks and J.C. Chatham, Differential modulation of glucose, lactate, and pyruvate oxidation by insulin and dichloroacetate in the rat heart. Am J Physiol Heart Circ Physiol, 2003. 285(1): p. H163–72.PubMed

28.

Sherry, A.D., C.R. Malloy, P. Zhao, et al., Alterations in substrate utilization in the reperfused myocardium: a direct analysis by 13C NMR. Biochemistry, 1992. 31(20): p. 4833–7.PubMedCrossRef

29.

Chatham, J.C. and A.M. Seymour, Cardiac carbohydrate metabolism in Zucker diabetic fatty rats. Cardiovasc Res, 2002. 55(1): p. 104–12.PubMedCrossRef

30.

Malloy, C.R., A.D. Sherry and F.M. Jeffrey, Carbon flux through citric acid cycle pathways in perfused heart by 13C NMR spectroscopy. FEBS Lett, 1987. 212(1): p. 58–62.PubMedCrossRef

31.

Ziegler, A., C.E. Zaugg, P.T. Buser, et al., Non-invasive measurements of myocardial carbon metabolism using in vivo 13C NMR spectroscopy. NMR Biomed, 2002. 15(3): p. 222–34.PubMedCrossRef

32.

Malloy, C.R., J.R. Thompson, F.M. Jeffrey, et al., Contribution of exogenous substrates to acetyl coenzyme A: measurement by 13C NMR under non-steady-state conditions. Biochemistry, 1990. 29(29): p. 6756–61.PubMedCrossRef

33.

Kettunen, M.I., D.E. Hu, T.H. Witney, et al., Magnetization transfer measurements of exchange between hyperpolarized [1-13C]pyruvate and [1-13C]lactate in a murine lymphoma. Magn Reson Med, 2010. 63(4): p. 872–80.PubMedCrossRef

34.

Randle, P.J., Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev, 1998. 14(4): p. 263–83.PubMedCrossRef

35.

Tyler, D.J., M.A. Schroeder, L.E. Cochlin, et al., Application of hyperpolarized magnetic resonance in the study of cardiac metabolism. Applied Magnetic Resonance, 2008. 34(3–4): p. 523–531.CrossRef

36.

Atherton, H.J., M.A. Schroeder, M.S. Dodd, et al., Validation of the in vivo assessment of pyruvate dehydrogenase activity using hyperpolarised (13)C MRS. NMR Biomed, 2010.

37.

Merritt, M.E., C. Harrison, C. Storey, et al., Inhibition of carbohydrate oxidation during the first minute of reperfusion after brief ischemia: NMR detection of hyperpolarized 13CO2 and H13CO3. Magn Reson Med, 2008. 60(5): p. 1029–36.PubMedCrossRef

38.

•• Schroeder, M.A., H.J. Atherton, D.R. Ball, et al., Real-time assessment of Krebs cycle metabolism using hyperpolarized 13C magnetic resonance spectroscopy. FASEB J, 2009. 23(8): p. 2529–38. This article demonstrates the first application of [2- ¹³ C]pyruvate for the assessment of real-time flux through the TCA cycle and the alterations to this flux that are seen following global ischemia in the perfused heart. PubMedCrossRef

39.

• Schroeder, M.A., P. Swietach, H.J. Atherton, et al., Measuring intracellular pH in the heart using hyperpolarized carbon dioxide and bicarbonate: a 13C and 31P magnetic resonance spectroscopy study. Cardiovasc Res, 2010. 86(1): p. 82–91. This article details the in vivo utilization of [1- ¹³ C]pyruvate for the assessment of intracellular pH in the heart with high temporal resolution. PubMed

40.

Moreno, K.X., S.M. Sabelhaus, M.E. Merritt, et al., Competition of pyruvate with physiological substrates for oxidation by the heart: implications for studies with hyperpolarized [1-13C]pyruvate. Am J Physiol Heart Circ Physiol, 2010. 298(5): p. H1556–64.PubMedCrossRef

41.

Schroeder, M.A., H.J. Atherton, L.E. Cochlin, et al., The effect of hyperpolarized tracer concentration on myocardial uptake and metabolism. Magn Reson Med, 2009. 61(5): p. 1007–14.PubMedCrossRef

42.

•• Lau, A.Z., A.P. Chen, N.R. Ghugre, et al., Rapid multislice imaging of hyperpolarized (13)C pyruvate and bicarbonate in the heart. Magn Reson Med, 2010. A new acquisition scheme is presented which allows for rapid, cardiac-gated acquisition of metabolic images with high spatial and temporal resolution.

43.

Comment, A., J. Rentsch, F. Kurdzesau, et al., Producing over 100 ml of highly concentrated hyperpolarized solution by means of dissolution DNP. J Magn Reson, 2008. 194(1): p. 152–5.PubMedCrossRef

44.

Jannin, S., A. Comment, F. Kurdzesau, et al., A 140 GHz prepolarizer for dissolution dynamic nuclear polarization. J Chem Phys, 2008. 128(24): p. 241102.PubMedCrossRef

45.

Johannesson, H., S. Macholl and J.H. Ardenkjaer-Larsen, Dynamic Nuclear Polarization of [1-13C]pyruvic acid at 4.6 tesla. J Magn Reson, 2009. 197(2): p. 167–75.PubMedCrossRef

46.

Cunningham, C.H., A.P. Chen, M.J. Albers, et al., Double spin-echo sequence for rapid spectroscopic imaging of hyperpolarized 13C. J Magn Reson, 2007. 187(2): p. 357–62.PubMedCrossRef

47.

Cunningham, C.H., A.P. Chen, M. Lustig, et al., Pulse sequence for dynamic volumetric imaging of hyperpolarized metabolic products. J Magn Reson, 2008. 193(1): p. 139–46.PubMedCrossRef

48.

Gallagher, F.A., M.I. Kettunen, S.E. Day, et al., Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate. Nature, 2008. 453(7197): p. 940–3.PubMedCrossRef

49.

Gallagher, F.A., M.I. Kettunen, S.E. Day, et al., 13C MR spectroscopy measurements of glutaminase activity in human hepatocellular carcinoma cells using hyperpolarized 13C-labeled glutamine. Magn Reson Med, 2008. 60(2): p. 253–7.PubMedCrossRef

50.

Gallagher, F.A., M.I. Kettunen, D.E. Hu, et al., Production of hyperpolarized [1,4-13C2]malate from [1,4-13C2]fumarate is a marker of cell necrosis and treatment response in tumors. Proc Natl Acad Sci U S A, 2009. 106(47): p. 19801–6.PubMed

Title: Cardiovascular Applications of Hyperpolarized MRI
Author: Damian J. Tyler
Publication date: 01-04-2011
Publisher: Current Science Inc.
Published in: Current Cardiovascular Imaging Reports / Issue 2/2011
Print ISSN: 1941-9066
Electronic ISSN: 1941-9074
DOI: https://doi.org/10.1007/s12410-011-9066-8

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Cardiovascular Applications of Hyperpolarized MRI

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2011

Modeling and Registration for Electrophysiology Procedures Based on Three-Dimensional Imaging

Measuring Treatment Effects in Clinical Trials Using Cardiac MRI

Myocardial Oxygenation Imaging: New Methods for Ischemia Detection

Toward Full Quantification of Wall Motion with MRI

MR and CT: When to Use Each

Does Late Enhancement Imaging Decipher the Role of Myocardial Fibrosis in Hypertrophic Cardiomyopathy?

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page